Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma

Journal of Pathology

Volumn 205, Issue 5, 2005, Pages 541-547

  Greiner, Axel ^a   Tobollik, Stephanie ^b   Buettner, Maike ^a   Jungnickel, Berit ^b   Herrmann, Kathrin ^a   Kremmer, Elisabeth ^c   Niedobitek, Gerald ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Activation induced cytidine deaminase; Classical; Hodgkin lymphoma; Immunohistochemistry; In situ hybridization; Nodular lymphocyte predominant

Indexed keywords

CYTIDINE DEAMINASE; FORMALDEHYDE; IMMUNOGLOBULIN CLASS; MONOCLONAL ANTIBODY; PARAFFIN;

ARTICLE; B LYMPHOCYTE; CANCER CELL; CONTROLLED STUDY; CYTOPLASM; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ENZYME ACTIVATION; ENZYME LOCALIZATION; GENE REARRANGEMENT; GENETIC RECOMBINATION; GERMINAL CENTER; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTE; LYMPHOCYTE TRANSFORMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC HYPERMUTATION; TISSUE SECTION;

ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; BLOTTING, WESTERN; CYTIDINE DEAMINASE; CYTOSINE DEAMINASE; GENE EXPRESSION; GERMINAL CENTER; HODGKIN DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 17144391393     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1746     Document Type: Article

References (22)

1. Besmer E, Gourzi P, Papavasiliou FN. The regulation of somatic hypermutation. Curr Opin Immunol 2004; 16: 241-245.
2. Honjo T, Muramatsu M, Fagarasan S. AID: how does it aid antibody diversity? Immunity 2004; 20: 659-668.
3. Coffman RL, Lebman DA, Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 1993; 54: 229-270.
4. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102: 553-563.
5. Revy P, Muto T, Levy Y, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 2000; 102: 565-575.
6. Muramatsu M, Sankaranand VS, Anant S, et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999; 274: 18 470-18 476.
7. Innerarity TL, Borén J, Yamanaka S, Olofsson S-O. Biosynthesis of apolipoprotein B48-containing lipoproteins. J Biol Chem 1996; 271: 2353-2356.
8. Ito S, Nagaoka H, Shinkura R, et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc Natl Acad Sci U S A 2004; 101: 1975-1980.
9. Begum NA, Kinoshita K, Muramatsu M, Nagaoka H, Shinkura R, Honjo T. De novo protein synthesis is required for activation-induced cytidine deaminase-dependent DNA cleavage in immunoglobulin class switch recombination. Proc Natl Acad Sci U S A 2004; 101: 13 003-13 007.
10. Pasqualucci L, Guglielmino R, Houldsworth J, et al. Expression of the AID protein in normal and neoplastic B cells. Blood 2004; 104: 3318-3325.
11. Shen HM, Storb U. Activation-induced cytidine deaminase (AID) can target both DNA strands when the DNA is supercoiled. Proc Natl Acad Sci U S A 2004; 101: 12 997-13 002.
12. Smit LA, Bende RL Aten J, Guikema JEJ, Aarts WM, van Noesel CJM. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res 2003; 63: 3894-3898.
13. Greeve J, Philipsen A, Krause K, et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 2003; 101: 3574-3580.
14. Küppers R, Rajewski K, Zhao M, et al. Hodgkin's disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A 1994; 91: 10 962-10 966.
15. Kanzler H, Küppers R, Hansmann M-L, Rajewski K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184: 1495-1505.
16. Marafioti T, Hummel M, Foss H-D, et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443-1450.
17. Braeuninger A, Kuppers R, Strickler JG, Wacker H-H, Rajewsky K, Hansmann M-L. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A 1997; 94 9337-9342.
18. Kuppers R, Schwering I, Brauninger A, Rajewsky K, Hansmann M-L. Biology of Hodgkin's lymphoma. Ann Oncol 2002; 13: 11-18.
19. Heussinger N, Buttner M, Ott G, et al. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma. J Pathol 2004; 203 696-699.
20. Niedobitek G, Herbst H. In situ detection of Epstein-Barr virus DNA and of viral gene products. In Epstein-Barr Virus Protocols, Wilson JB, May GHW (eds). Humana Press: Totowa, NJ, 2001; 79-91.
21. Kanzler H, Kuppers R, Helmes S, et al. Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood 2000; 95: 1023-1031.
22. Schwering I, Brauninger A, Klein U, et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2003; 101: 1505-1512.